Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 276, 157-167
Abstract
No abstract availableKeywords
Funding Information
- Marie Curie Initial Training Network PathChooser (PITN-GA-2013-608373)
- Wellcome Trust
- University of Manchester
This publication has 44 references indexed in Scilit:
- Temperature: The “Ignored” Factor at the NanoBio InterfaceACS Nano, 2013
- Protein corona significantly reduces active targeting yieldChemical Communications, 2013
- Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surfaceNature Nanotechnology, 2013
- Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia in Vitro and in VivoACS Nano, 2012
- Binding of blood proteins to carbon nanotubes reduces cytotoxicityProceedings of the National Academy of Sciences, 2011
- Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro systemJournal of Controlled Release, 2011
- Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local CancerThe Open Nanomedicine Journal, 2011
- The functional roles of poly(ethylene glycol)‐lipid and lysolipid in the drug retention and release from lysolipid‐containing thermosensitive liposomes in vitro and in vivoJournal of Pharmaceutical Sciences, 2010
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences, 2007
- Effect of bovine serum on the phase transition temperature of cholesterol-containing liposomesJournal of Microencapsulation, 1998